The following table describes the data elements displayed in the NCI As Sponsor Trials report for each trial:
Data Element | Description |
---|---|
NCI ID | The |
Lead Org ID | The For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. |
Title | The For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. |
Lead Organization PO ID | The unique ID assigned to the lead organization by the CTRP. For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. |
Lead Organization | The For more information, refer to Abstracting Sponsors and Responsible Parties. |
NCT ID | The For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. |
CTEP ID | The For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. |
DCP ID | The For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. |
Funding Mechanism | A For more information, refer to Abstracting Funding. |
NCI Division/Program | The NCI division or program identified in an IND, IDE, or grant record, as the For more information, refer to Abstracting INDs and IDEs or Abstracting Funding. |
Institution Code | The NIH institution associated with the trial, as identified in an IND or IDE record. It is a For more information, refer to Abstracting INDs and IDEs. |
IND/IDE Grantor | The For more information, refer to Abstracting INDs and IDEs. |
IND/IDE Holder Type | The For more information, refer to Abstracting INDs and IDEs. |
IND/IDE Number | The For more information, refer to Abstracting INDs and IDEs. |
IND/IDE Types | Value indicating For more information, refer to Abstracting INDs and IDEs. |
Section 801 Indicator | Value indicating For more information, refer to Abstracting Regulatory Information. |
Principal Investigator | The For more information, refer to Abstracting Sponsors and Responsible Parties. |
Sponsor Org | The For more information, refer to Abstracting Sponsors and Responsible Parties. |
Responsible Party | The For more information, refer to Abstracting Sponsors and Responsible Parties. |
Summary 4 Funding Sponsor | The For more information, refer to Abstracting Sponsors and Responsible Parties. |
Trial Status | The For details, refer to Trial Status Values in the CTRP and ClinicalTrials.gov and Abstracting Trial Statuses. |
Trial Status Date | The For more information, refer to Abstracting Trial Statuses. |
Trial Start Date | The For more information, refer to Abstracting Trial Statuses. |
Primary Completion Date | The For more information, refer to Abstracting Trial Statuses. |
Primary Completion Date Type | A For more information, refer to Abstracting Trial Statuses. |
Submitting Org Name | The name of the organization that submitted the trial. |
Current Processing Status | The For information, refer to Trial Processing Statuses and Abstracting Trial Statuses. |
Study Category | The For more information, refer to Abstracting NCI-Specific Information. |
Submission Number | A For more information, refer to Processing Trial History Information. |
Trial Submission Type | A value indicating For more information, refer to Processing Trial History Information. |
Trial Summary Report Sent Date | The date on which the system sent the Trial Summary Report (TSR) to the principal investigator or trial submitter. For more information, refer to Processing Trial Milestones. |